Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Tauopathies: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Tauopathies describes a key molecular or cellular mechanism implicated in neurodegenerative disease. This page provides a detailed overview of the pathway components, signaling cascades, and their relevance to conditions such as Alzheimer's disease, Parkinson's disease, and related disorders. [@mand
| Name | Tauopathies |
| Key Genes/Proteins | TAU PROTEIN, TRIM11, TAU, MAPT, DNAJB6 |
| Related Diseases | Tau Hyperphosphorylation, Abnormal Tau Phosphorylation |
| Related Pathways | Endosomal-Lysosomal Dysfunction, Endosomal-Lysosomal-Exosome Pathway, Tau Acetylation, cGAS-STING Signaling, Tau Phosphorylation Inhibition |
Knowledge base pages for this entity
graph TD
Tauopathies["<b>Tauopathies</b>"]
Tau_Aggregation(["Tau Aggregation"])
Tauopathies -->|"causes"| Tau_Aggregation
TAU_PROTEIN["TAU PROTEIN"]
Tauopathies -->|"biomarker for"| TAU_PROTEIN
TRIM11["TRIM11"]
Tauopathies -->|"protects against"| TRIM11
TAU["TAU"]
Tauopathies -->|"causes"| TAU
Tau_Hyperphosphorylation["Tau Hyperphosphorylation"]
Tauopathies -->|"biomarker for"| Tau_Hyperphosphorylation
Abnormal_Tau_Phosphorylation["Abnormal Tau Phosphorylation"]
Tauopathies -->|"contributes to"| Abnormal_Tau_Phosphorylation
MAPT["MAPT"]
Tauopathies -->|"causes"| MAPT
Alzheimer_S_Disease{"Alzheimer'S Disease"}
Tauopathies -->|"implicated in"| Alzheimer_S_Disease
Neurodegenerative_Disease{"Neurodegenerative Disease"}
Tauopathies -->|"implicated in"| Neurodegenerative_Disease
Parkinson_S_Disease{"Parkinson'S Disease"}
Tauopathies -->|"implicated in"| Parkinson_S_Disease
Tauopath{"Tauopath"}
Tauopathies -->|"implicated in"| Tauopath
PARKIN["PARKIN"]
Tauopathies ---|"interacts"| PARKIN
style Tauopathies fill:#2a1a3a,stroke:#b39ddb,stroke-width:3px,color:#fff
style Parkinson_S_Disease fill:#4a1a1a,stroke:#ef5350,stroke-width:1px,color:#ef5350
style Alzheimer_S_Disease fill:#4a1a1a,stroke:#ef5350,stroke-width:1px,color:#ef5350
style Neurodegenerative_Disease fill:#4a1a1a,stroke:#ef5350,stroke-width:1px,color:#ef5350
style Tauopath fill:#4a1a1a,stroke:#ef5350,stroke-width:1px,color:#ef5350| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| Tau Aggregation | causes | process | 0.95 |
| TAU PROTEIN | biomarker_for | protein | 0.95 |
| TAU PROTEIN | involved_in | protein | 0.95 |
| TRIM11 | protects_against | protein | 0.90 |
| TAU | causes | protein | 0.90 |
| Tau Hyperphosphorylation | biomarker_for | phenotype | 0.90 |
| Abnormal Tau Phosphorylation | contributes_to | phenotype | 0.90 |
| MAPT | causes | protein | 0.85 |
| Endosomal-Lysosomal Dysfunction | contributes_to | mechanism | 0.85 |
| Endosomal-Lysosomal-Exosome Pathway | therapeutic_target | pathway | 0.85 |
| Tau Acetylation | associated_with | mechanism | 0.85 |
| cGAS-STING Signaling | involved_in | pathway | 0.80 |
| DNAJB6 | protects_against | protein | 0.80 |
| Tau Phosphorylation Inhibition | protects_against | mechanism | 0.75 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-10 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||